H.R. 7658 · 117th Congress · House

To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Active· Referred to the House Committee on Energy and Commerce.
Introduced
May 3, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending
S. 4348
117th Congress
FDASLA Act of 2022

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Related bill
by CRS
Jul 13, 2022
S. 4348
117th Congress
FDASLA Act of 2022

Placed on Senate Legislative Calendar under General Orders. Calendar No. 444.

Related bill
by CRS
Jul 13, 2022
H.R. 7667
117th Congress
Food and Drug Amendments of 2022

Received in the Senate.

Related bill
by CRS
Jun 9, 2022
H.R. 7667
117th Congress
Food and Drug Amendments of 2022

Received in the Senate.

Related bill
by CRS
Jun 9, 2022
S. 4152
117th Congress
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Identical bill
by CRS
May 5, 2022
S. 4152
117th Congress
A bill to amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships.

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Identical bill
by CRS
May 5, 2022